Related Experiment Videos
Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents
J C Sipe1, M Filippi, G Martino
1Neuroimaging Research Unit, San Raffaele Hospital, Milan, Italy. sipe.jack@hsr.it
Abstract:
A method for intracellular iron labeling of human mononuclear cells (lymphocytes and monocytes) for magnetic resonance imaging (MRI) using simple incubation of cells with approved MRI iron contrast agents is presented. Labeled cells can be detected by MRI in vitro, and this suggests the possibility that the technique could become a marker for in vivo lymphocyte and monocyte trafficking studies in acute inflammatory lesions such as those in Multiple Sclerosis.
Insights
Researchers developed a method to label human immune cells with iron for MRI. This technique allows for tracking cell movement in conditions like Multiple Sclerosis.
Area of Science:
- Biomedical Imaging
- Cellular Biology
- Immunology
Background:
- Tracking immune cell (lymphocytes and monocytes) trafficking is crucial for understanding inflammatory diseases.
- Current methods for cell tracking may be limited in sensitivity or specificity.
Purpose of the Study:
- To present a novel method for intracellular iron labeling of human mononuclear cells.
- To evaluate the feasibility of using this method for Magnetic Resonance Imaging (MRI) applications.
Main Methods:
- Human mononuclear cells (lymphocytes and monocytes) were incubated with approved MRI iron contrast agents for intracellular labeling.
- Labeled cells were subsequently analyzed using MRI to assess detection capabilities in vitro.
Main Results:
- Successful intracellular iron labeling of human lymphocytes and monocytes was achieved.
- MRI was able to detect the iron-labeled cells effectively in vitro.
Conclusions:
- The developed method offers a promising approach for intracellular iron labeling of mononuclear cells.
- This technique holds potential as a non-invasive marker for studying in vivo lymphocyte and monocyte trafficking in inflammatory conditions, including Multiple Sclerosis.